| Year | Firm | Client | Income | Doc |
|---|---|---|---|---|
| 2025 1st Quarter - Report |
2359 STRATEGIES | THE FIBROID FOUNDATION | — | |
| 2025 1st Quarter - Report |
2359 STRATEGIES | FEDERAL STREET STRATEGIES LLC | — | |
| 2025 1st Quarter - Report |
2359 STRATEGIES | TRAVERE THERAPEUTICS | $12,000 | |
| 2024 4th Quarter - Report |
2359 STRATEGIES | THE FIBROID FOUNDATION | — | |
| 2024 4th Quarter - Report |
2359 STRATEGIES | FEDERAL STREET STRATEGIES LLC | — | |
| 2024 4th Quarter - Report |
2359 STRATEGIES | TRAVERE THERAPEUTICS | $12,000 | |
| 2024 3rd Quarter - Report |
2359 STRATEGIES | THE FIBROID FOUNDATION | — | |
| 2024 3rd Quarter - Report |
2359 STRATEGIES | FEDERAL STREET STRATEGIES LLC | — | |
| 2024 3rd Quarter - Report |
2359 STRATEGIES | TRAVERE THERAPEUTICS | $12,000 | |
| 2024 2nd Quarter - Report |
2359 STRATEGIES | THE FIBROID FOUNDATION | — |